CropScience will miss EBITDA target

Williams, Dede
September 2006
ICIS Chemical Business;9/25/2006, Vol. 1 Issue 36, p5
Trade Publication
This article reports on an announcement by Bayer CropScience CEO Friedrich Berschauer in Monheim, Germany that his firm will not achieve its targeted earnings before interest, taxes, depreciation and amortization margin in 2006. This is due to adverse weather in Europe and North America and the ongoing economic squeeze in Brazil.


Related Articles

  • Plant biotech is the future, concludes science forum. Cozier, Muriel // European Chemical News;9/27/2004, Vol. 81 Issue 2117, p36 

    Reports on the use of plant biotechnology to meet the global demand for food, feed and modern textile fibers according to the annual science forum of Bayer CropScience held in Gent, Belgium in September 2004. Commitment of Bayer CropScience in plant biotechnology; Comments of Friedrich...

  • Bayer Shuffles Agchem Portfolio and Launches New Ingredients. Alperowicz, Natasha // Chemical Week;9/20/2010, Vol. 172 Issue 22, p13 

    The article considers the plans of Bayer CropScience (BCS) to improve its portfolio of crop protection agents and high-quality seeds. According to BCS Friedrich Berschauer, the company aims to introduce new products and improve plant traits. The company will terminate the manufacturing of 21...

  • Bayer developing product pipeline.  // Southeast Farm Press;6/15/2005, Vol. 32 Issue 16, p29 

    The article reports that Friedrich Berschauer, Bayer CropScience AG's chairman of the board, has said that new products have fueled the company to the top position in worldwide agricultural chemical sales three years after the merger that created the firm. The firm expects at least seven...

  • Bayer CropScience to Triple Bioscience Sales; Details Cuts. Alperowicz, Natasha // Chemical Week;9/27/2006, Vol. 168 Issue 32, p17 

    The article reports on the strategy of agricultural chemical producer Bayer CropScience to triple sales of its bioscience business. According to CEO Friedrich Berschauer, the company is embarking on two separate projects such as the restructuring in the firm's crop protection business. The...

  • Seeds of change. Lerner, Ivan // ICIS Chemical Business;6/16/2008, Vol. 273 Issue 24, p26 

    The article reports on the demand for agricultural chemicals in the global market for agricultural products. Friedrich Berschauer, chairman of the board of Germany's Bayer CropScience Ltd., the key factory that are driving longer-term market developments are the world's growing population and...

  • Bayer Upbeat on Agchems; Eyes Biofuels Opportunities. Alperowicz, Natasha // Chemical Week;9/19/2007, Vol. 169 Issue 30, p15 

    The article reveals that Bayer CropScience is optimistic about the future of the agrochemicals industry and is exploring new opportunities in the sector, according to Friedrich Berschauer, chairman of Bayer CropScience. Bayer commands 17%-18% of the global €25 billion-€26 billion...

  • Agrochemical giants can capture growth. Davis, Nigel // ICIS Chemical Business;9/15/2008, Vol. 274 Issue 10, p15 

    The article reports that the world's major agrochemical companies had a banner year in 2007, and 2008 looks even stronger. Agribusiness consultancy Phillips McDougall says that, overall, agrochemical sales were up by 29% in the first half. Big sector players are well laced to innovate and Bayer...

  • Bayer CropScience Expects Major Portfolio Shift. Alpercwicz, Natasha // Chemical Week;12/20/2006, Vol. 168 Issue 43, p13 

    The article reports that Bayer CropScience Ltd. expects its portfolio to go through a major change in focus by 2015, as the company battles with a shrinking market for conventional crop protection products. About 72% of the agrochemicals manufacturer's total sales in 2015 will be derived from...

  • Bayer Unveils Agchem Plans; Ups Pipeline Estimates. ALPEROWICZ, NATASHA // Chemical Week;9/19/2011, Vol. 173 Issue 23, p14 

    The article focuses on the plans of agricultural chemicals producer Bayer CropScience for 2011. Bayer changed its earnings guidelines to include sales improvement based on currency and portfolio. It also plans to expand Ebitda before special items by approximately 20 percent. According to Sandra...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics